IL-1 Signal Inhibition in Alcoholic Hepatitis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
- Status
- COMPLETED
- Phase
- PHASE3
A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis
- Status
- COMPLETED
- Phase
- PHASE2
HDM201 Added to CT in R/R or Newly Diagnosed AML
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy of PEAR-004 in Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- NA
Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).
- Status
- TERMINATED
- Phase
- PHASE1
Managed Access Programs for SEG101, Crizanlizumab
- Status
- AVAILABLE
- Phase
- N/A
Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function
- Status
- TERMINATED
- Phase
- PHASE2
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
- Status
- COMPLETED
- Phase
- PHASE3
This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).
- Status
- COMPLETED
- Phase
- PHASE3
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
- Status
- TERMINATED
- Phase
- PHASE3
Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Determine Safety and Dose of NJH395 in Non-breast HER2+ Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma
- Status
- COMPLETED
- Phase
- PHASE3